Vaxcyte Inc (PCVX)

May 24, 2025

How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com

May 24, 2025

May 20, 2025

James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University

May 20, 2025

May 13, 2025

Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025

May 11, 2025

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

May 11, 2025

May 09, 2025

Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back? - MSN

May 09, 2025

May 09, 2025

Vaxcyte, Inc. Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

11 Stocks That Will Bounce Back According to Analysts - Insider Monkey

May 08, 2025

May 08, 2025

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus

May 08, 2025

May 07, 2025

Vaxcyte (PCVX) Advances Pneumococcal Vaccine Development | PCVX Stock News - GuruFocus

May 07, 2025

May 07, 2025

Vaxcyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025

May 07, 2025

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 07, 2025

May 07, 2025

Vaxcyte Inc Reports Q1 2025 EPS of -$1.04, Beating Estimates; Net Loss Widens to $140.7 Million - GuruFocus

May 07, 2025

May 06, 2025

Oversold Conditions For Vaxcyte (PCVX) - Nasdaq

May 06, 2025

May 03, 2025

Vaxcyte (PCVX) Stock Price, News & Analysis - MarketBeat

May 03, 2025

May 01, 2025

Vaxcyte appoints new independent director - Investing.com Australia

May 01, 2025

May 01, 2025

Vaxcyte appoints new independent director By Investing.com - Investing.com South Africa

May 01, 2025

May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025

May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors - GuruFocus

May 01, 2025

May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board - TipRanks

May 01, 2025

May 01, 2025

Vaxcyte adds former Sanofi CEO to its board - Investing.com

May 01, 2025

May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025

May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - The Manila Times

May 01, 2025

Apr 29, 2025

Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now? - Yahoo Finance

Apr 29, 2025

Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025

Apr 24, 2025

PCVXVaxcyte, Inc. Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025

Apr 24, 2025

James T. Wassil ’99G ’05G of Vaxcyte, Inc. Named Lehigh’s 2025 Graduate Commencement and Doctoral Hooding Ceremony Speaker - Lehigh University

Apr 24, 2025

Apr 22, 2025

Vaxcyte (PCVX) Gains Attention with Overweight Rating Amid Marke - GuruFocus

Apr 22, 2025

Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz - GuruFocus

Apr 21, 2025

Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz | PCVX Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Commit To Buy Vaxcyte At $20, Earn 14.7% Annualized Using Options - Nasdaq

Apr 21, 2025

Apr 21, 2025

TD Cowen Keeps Their Buy Rating on Vaxcyte (PCVX) - The Globe and Mail

Apr 21, 2025

Apr 18, 2025

When the Price of (PCVX) Talks, People Listen - news.stocktradersdaily.com

Apr 18, 2025

Apr 17, 2025

2 ‘Strong Buy’ Growth Stocks That Could Gain More Than 340% - The Globe and Mail

Apr 17, 2025

Apr 16, 2025

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 16, 2025

Apr 12, 2025

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason - MSN

Apr 12, 2025

Apr 11, 2025

Vaxcyte Stock Plummets: What’s Next? - timothysykes.com

Apr 11, 2025

Apr 11, 2025

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential - Insider Monkey

Apr 11, 2025

Apr 09, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges - Investing.com India

Apr 09, 2025

Apr 08, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 05, 2025

Vaxcyte (NASDAQ:PCVX) Price Target Lowered to $137.00 at Bank of America - MarketBeat

Apr 05, 2025

Apr 02, 2025

InvestingPro Fair Value model correctly predicted Vaxcyte’s decline By Investing.com - Investing.com UK

Apr 02, 2025

Apr 02, 2025

Vaxcyte (NASDAQ:PCVX) Given New $137.00 Price Target at Bank of America - Defense World

Apr 02, 2025